AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11057001
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of orthographic and phonological cues
Trial: 8853729
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg beta-carotene orally three times daily and multivitamins
Trial: 6391665
Drug: Stuart Prenatal
RxNorm normalized name: Stuart Prenatal + DHA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stuart Prenatal tablets
Trial: 29270622
Drug: External Vibration
RxNorm normalized name: VIBRATING DEVICE,CONSTIPATION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External Vibration Therapy (EVT)
Trial: 25901558
Drug: Low-dose CT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CT (LDCT)
Trial: 7726440
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion (2.4 +/- 0.7 mg.kg‐1.h‐1)
Trial: 7726440
Drug: Single nonsedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single nonsedating bolus dose propofol (0.4 mg/kg)
Trial: 1768821
Drug: Various strategies
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various strategies to manage cardiopulmonary bypass (hypothermia vs normothermia, presence vs absence of arterial microfilters, presence vs absence of glucose-containing solution in pump prime)
Trial: 3138303
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg twice daily)
Trial: 12940397
Drug: Hypnotic Stress
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic Stress Inoculation Training
Trial: 12940397
Drug: Hypnotic analgesia
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic analgesia suggestions
Trial: 12940397
Drug: Hypnotic induction
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic induction treatment
Trial: 3803414
Drug: Oral verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral verapamil (Isoptin) b.d. or t.d.s. (240, 360 or 480 mg daily)
Trial: 24495617
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (ND) co-administration
Trial: 24495617
Drug: Screening using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Screening using urine steroid and LH measurements
Trial: 23210198
Drug: Conventional orthodontic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional orthodontic therapy
Trial: 20671206
Drug: Individualized oral
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized oral hygiene instruction (OHI)
Trial: 20671206
Drug: OHI and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OHI and annual applications of 38% silver diamine fluoride (SDF) solution
Trial: 18701006
Drug: Sublingual specific
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual specific immunotherapy (SLIT), treated daily for at least two consecutive years.
Trial: 8232945
Drug: Gabapentin (600,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (600, 1,200, or 1,800 mg/d)
Trial: 27103371
Drug: GLP-1 infusion
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 infusion for 4h
Trial: 27103371
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of normoglycemia and GLP-1 for 4h
Trial: 27103371
Drug: Hyperglycemia plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperglycemia plus GLP-1 infusion for 4h
Trial: 25579357
Drug: Bimatoprost 0.03%
RxNorm normalized name: BIMATOPROST 0.03% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost 0.03% eye drops once daily for 4 weeks
Trial: 19996339
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation solution (TIS) 300 mg/5 ml twice daily for 56 days
Trial: 19996339
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation solution (TIS) 300 mg/5 ml twice daily for 28 days (control group)
Trial: 22170727
Drug: Rimonabant 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant 20 mg/d
Trial: 12088975
Drug: Tropisetron 2
RxNorm normalized name: tropisetron
DrugBank: Tropisetron (DB11699)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 2 mg IV
Trial: 10218187
Drug: Therapy dog
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy dog
Trial: 2669441
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg clomipramine
Trial: 1095963
Drug: Fructose-1-6-diphosphate sodium
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fructose-1-6-diphosphate sodium salt intravenously administered for 20 days at two daily doses of 2.5 mg
Trial: 28679495
Drug: Vaccine containing
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine containing 80 μg sF with 2.5 μg GLA in SE
Trial: 28408121
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza vaccine (IIV)
Trial: 3044425
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg
Trial: 6689676
Drug: Nifedipine 30
RxNorm normalized name: nifedipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 30 mg
Trial: 26813677
Drug: G.H.3. tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G.H.3. tablets
Trial: 23083925
Drug: Atropine (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.04 mg/kg) administered at peak exercise during session #2
Trial: 17023713
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg DHA + 150 mg eicosapentaenoic acid, 400 microg 5‐methyl‐tetrahydrofolic acid
Trial: 19492924
Drug: Outpatient cervical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient cervical ripening by prostaglandins or other cervical ripening agents
Trial: 10211515
Drug: Medical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medical bowel confinement (clear liquid diet with loperamide 4 mg three times per day and codeine phosphate 30 mg four times per day until the third postoperative day)
Trial: 113806
Drug: Hypnotic analgesia
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic analgesia with naloxone
Trial: 113806
Drug: Hypnotic analgesia
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic analgesia with placebo
Trial: 6357258
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of penbutolol and frusemide
Trial: 31340789
Drug: Probiotic strains
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic strains Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14, administered orally (one capsule daily) until negative HR-HPV testing.
Trial: 22974092
Drug: Changes in
RxNorm normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Canges XP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Changes in tumor marker levels during treatment
Trial: 21990564
Drug: Intra-arterial thrombolysis
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial thrombolysis (IAT) with up to 0.9 mg/kg alteplase over 60 min
Trial: 21990564
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis (IVT) with alteplase according to European labeling
Trial: 8485825
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor treatment (specific drug not mentioned)
Trial: 2866047
Drug: Metoprolol (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (150 mg/day)
Trial: 2006616
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg/day)
Trial: 19387386
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g per day, 4 doses of 5 g per day)
Trial: 11803729
Drug: Amisulpride (100-1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (100-1200 mg/day)
Trial: 9617983
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium (220 mg every 8 hours)
Trial: 9617983
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (300 mg every 12 hours) with acetaminophen
Trial: 2532921
Drug: Frusemide (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (30 mg)
Trial: 2532921
Drug: Frusemide (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (30 mg) with ramipril (5 mg) pretreatment
Trial: 788889
Drug: Cyclophosphamide, 10
RxNorm normalized name: Cyclophosphamide, 100 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide, 10 mg/kg/day orally for 7-10 days every 28 days for 1 year
Trial: 22193786
Drug: Best practices
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best practices model within the juvenile court system for early mental health intervention, including screening with the Youth Outcome Questionnaire and treatment involving psychiatric care and in-home behavioral intervention.
Trial: 11568790
Drug: Ceftriaxone 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 125 mg intramuscularly
Trial: 27236082
Drug: Cross-sex hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cross-sex hormone treatment (4 weeks and 4 months duration) in MtF and FtM transgender individuals
Trial: 23672386
Drug: 3.5 mL
RxNorm normalized name: ethanol 3.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 mL menthol gel
Trial: 23672386
Drug: 3.5 mL
RxNorm normalized name: ethanol 3.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 mL of menthol gel and 0.5 kg of crushed ice
Trial: 10233876
Drug: PIXY321 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PIXY321 administered subcutaneously in divided doses of 135, 250, 500, 750, and 1,000 micrograms/m2/d during cycles 2 and later
Trial: 10233876
Drug: PIXY321 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PIXY321 administered during cycles A-2 and B-1
Trial: 7982342
Drug: Pharmacologic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic treatment with bronchodilators and anti-inflammatory agents
Trial: 7982342
Drug: Adjunctive and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive and nonconventional therapy
Trial: 31905607
Drug: 40-g protein
RxNorm normalized name: soy protein isolate 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40-g protein drink
Trial: 25322870
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of daily living (ADLs) and cognitive assessment
Trial: 17229660
Drug: 40% of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40% of total daily insulin requirement
Trial: 17229660
Drug: 60% of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60% of total daily insulin requirement
Trial: 17229660
Drug: 80% of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80% of total daily insulin requirement
Trial: 3234467
Drug: Simvastatin 20‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20‐40 mg/day
Trial: 8560901
Drug: Bezafibrate 600
RxNorm normalized name: bezafibrate
DrugBank: Bezafibrate (DB01393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate 600 mg/day
Trial: 16861095
Drug: Levetiracetam 1,500
RxNorm normalized name: levetiracetam 1,500 mg ORAL TABLET, EXTENDED RELEASE 24 HR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam 1,500 mg IV infusion
Trial: 16861095
Drug: Levetiracetam 500
RxNorm normalized name: levetiracetam 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam 500 mg oral tablets
Trial: 16861095
Drug: Levetiracetam 1,500
RxNorm normalized name: levetiracetam 1,500 mg ORAL TABLET, EXTENDED RELEASE 24 HR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam 1,500 mg IV infusion (multiple doses)
Trial: 28929521
Drug: Placebo (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (multiple doses)
Trial: 12646326
Drug: Standard Treatment
RxNorm normalized name: Azo-Standard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard Treatment (tapered dosing regimen)
Trial: 24925584
Drug: Novolin® 30R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novolin® 30R (initial dose 0.5 IU/kg)
Trial: 12534411
Drug: Rabeprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (10 mg b.d.) + Amoxicillin (750 mg b.d.) + Clarithromycin (400 mg b.d.)
Trial: 12534411
Drug: Lansoprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (30 mg b.d.) + Amoxicillin (750 mg b.d.) + Clarithromycin (400 mg b.d.)
Trial: 10497402
Drug: Step‐by‐step pharmacologic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step‐by‐step pharmacologic therapy including bronchodilators (beta 2‐agonists, anticholinergic agents), theophylline, and oral corticosteroids
Trial: 1849810
Drug: Ketanserin 20
RxNorm normalized name: ketanserin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 20 mg single oral dose
Trial: 1849810
Drug: Ketanserin 20
RxNorm normalized name: ketanserin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 20 to 40 mg twice daily for 4 weeks
Trial: 7000631
Drug: PGE2 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE2 (1 mg four times daily) with ASA (600 mg four times daily)
Trial: 31152605
Drug: Brentuximab vedotin
RxNorm normalized name: Brentuximab Vedotin
DrugBank: Brentuximab vedotin (DB08870)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brentuximab vedotin (1.2 mg/kg every 2 weeks)
Trial: 28067718
Drug: Safety assessment
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Safety assessment of both vaccines
Trial: 9207314
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and gemcitabine combination
Trial: 9207314
Drug: Supportive care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive care plus cisplatin-based chemotherapy
Trial: 2442788
Drug: Reserpine 5
RxNorm normalized name: hydralazine HCl/reserpine 50-0.2MG ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reserpine 5 mg IM b.i.d. over 2 days (placebo-controlled, double-blind trial)
Trial: 2442788
Drug: Desipramine (DMI)
DrugBank: Desipramine (DB01151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desipramine (DMI) treatment
Trial: 2442788
Drug: Reserpine augmentation
RxNorm normalized name: Reserpine
DrugBank: Reserpine (DB00206)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reserpine augmentation
Trial: 29486353
Drug: Antibiotic +
RxNorm normalized name: Antibiotic + Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic + indocyanine green + 810 nm wavelength diode laser (antimicrobial photodynamic therapy group)
Trial: 29486353
Drug: Antibiotic alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic alone (control group)
Trial: 26836801
Drug: Moxibustion treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxibustion treatment daily for two weeks
Trial: 25260838
Drug: Pasireotide 40
RxNorm normalized name: pasireotide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 40 mg
Trial: 27280398
Drug: Pasireotide 60
RxNorm normalized name: pasireotide 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 60 mg
Trial: 23581697
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone undecanoate 240 mg/d
Trial: 23581697
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone undecanoate 80 mg/d, 160 mg/d, 240 mg/d
Trial: 18972728
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy group (active exercise after passive exercise)
Trial: 30938762
Drug: Comparator (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator (placebo or active comparator: sitagliptin 100 mg, exenatide extended release 2.0 mg)
Trial: 28424190
Drug: Inulin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inulin (30 g/d)
Trial: 28424190
Drug: Propionate (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionate (6 g/d)
Trial: 28424190
Drug: Cellulose (30
RxNorm normalized name: hydroxyethyl cellulose (3000 CPS at 1%)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellulose (30 g/d)
Trial: 25154757
Drug: Dipyrone (575
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone (575 mg, three times a day for 72 hr)
Trial: 25154757
Drug: Acetaminophen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (500 mg, three times a day for 72 hr)
Trial: 24107481
Drug: Docetaxel 40
RxNorm normalized name: docetaxel 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel 40 mg/m² and cisplatin 40 mg/m² biweekly on days 1 and 15 every 4 weeks
Trial: 21375777
Drug: Single-dose AmBisome®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose AmBisome® (7.5 mg/kg, escalating to 10, 12.5, and 15 mg/kg if ineffective)
Trial: 21375777
Drug: Multi-dose AmBisome®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-dose AmBisome® (3 mg/kg/day on days 1-5, 14, and 21; total dose 21 mg/kg)
Trial: 21375777
Drug: Single-dose AmBisome®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose AmBisome®
Trial: 21375777
Drug: Multi-dose AmBisome®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-dose AmBisome®
Trial: 19533313
Drug: Active allergen
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active allergen immunotherapy (IT) with single insect extract (cockroach, housefly, or mosquito) and mixed allergen IT (two or three insect extracts)
Trial: 12538427
Drug: L‐NMMA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐NMMA
Trial: 10648310
Drug: Oral ketamine/midazolam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine/midazolam
Trial: 10648310
Drug: Intramuscular meperidine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular meperidine, promethazine, and chlorpromazine (DPT)
Trial: 8862501
Drug: Bromocriptine (BRC,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (BRC, 2.5 mg po)
Trial: 1738963
Drug: One-dose regimen
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-dose regimen of cefuroxime
Trial: 6469757
Drug: Misonidazole treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misonidazole treatment
Trial: 20551634
Drug: Intravaginal pentamycin
RxNorm normalized name: Benzamycin
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal pentamycin 3, 10, 30, 60 or 100 mg
Trial: 20551634
Drug: Intravaginal pentamycin
RxNorm normalized name: Benzamycin
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal pentamycin 60 mg
Trial: 12394817
Drug: PnCV reconstituted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PnCV reconstituted in TETRAMUNE as a single injection in the right thigh (combined)
Trial: 25800457
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate once‐monthly injectable antipsychotic (PP1M)
Trial: 25800457
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate adjunctive therapy (PP1M)